UnitedHealth Group (UNH) has sold an interest in its Florida WellMed primary-care clinics to private equity firm TPG (TPG), Bloomberg reported on 9 September 2026. The clinics sit inside Optum Health, UnitedHealth’s care-delivery arm.
UNH shares fell as much as 3% to $388.58 in early trading, according to 24/7 Wall St. Consolidated exchange data in the same window showed the stock down 2.77% to $388.94 by 3pm UTC, with volume 1.71 times the 20-day average.
Terms undisclosed, rationale framed as growth
Neither company disclosed financial terms of the WellMed clinics sale. Optum Health chief executive Krista Nelson said the tie-up with TPG was meant to bring in fresh capital and expertise for strategic growth, according to the Bloomberg report carried by Insurance Journal.
UnitedHealth chief financial officer Wayne DeVeydt characterised the arrangement as a local partnership rather than a capital raise, according to Yahoo Finance. The deal was also flagged separately by Seeking Alpha.
The move is not TPG’s first bite at UnitedHealth’s clinic portfolio. The firm previously bought Optum UK from UnitedHealth in a sale that UnitedHealth said generated $400m for the United Health Foundation, per the Bloomberg reporting. That precedent makes the Florida transaction look less like an isolated disposal and more like a repeatable route for shedding capital-intensive pieces of Optum Health.
Guidance reaffirmed at Wells Fargo conference
The stake sale emerged the same day UnitedHealth executives appeared at the Wells Fargo 21st Annual Healthcare Conference, where the company discussed progress on its broader turnaround, according to a transcript carried by Investing.com. DeVeydt used the platform to guide Optum Health operating margins to around 2% this year, rising to roughly 4% in 2027 and 6% the year after, Insurance Journal reported.
Those targets follow a rough patch. Optum Health’s operating margins turned negative last year as healthcare costs rose and federal payment restrictions bit, a slide that prompted a leadership shake-up at UnitedHealth, according to the Bloomberg account. The Florida disposal fits that repair effort: trimming exposure to a clinic network that has weighed on group profitability.
UnitedHealth’s own quarterly filings show how volatile that period has been. Net income swung from a $1.409bn loss in the first quarter of 2024 to positive results of several billion dollars in every quarter since, including $5.484bn in the second quarter of 2026, according to SEC filings. Group revenue has climbed steadily over the same stretch, from $99.8bn in the first quarter of 2024 to $112bn in the second quarter of this year, per the company’s latest 10-Q.
Sector move or single stock story?
The reaction looked specific to UnitedHealth rather than a healthcare-wide repricing. The Health Care Select Sector SPDR Fund (XLV) fell only 0.4% the same day, 24/7 Wall St. noted, well short of UNH’s decline.
No 8-K or other SEC filing in UnitedHealth’s public record discloses terms of the transaction, consistent with a minority-stake sale that falls below the threshold for a material-event disclosure rather than any gap in the reporting.
For TPG, the deal extends an active push into healthcare services. The firm ended the second quarter of 2026 with $326.8bn in assets under management and $76.2bn in available capital, and has been building out senior-care buyout platforms, according to 24/7 Wall St. Whether more pieces of Optum Health follow WellMed’s Florida clinics out of UnitedHealth’s portfolio is likely to be a question for the company’s next earnings call.
This article is for information only and is not investment advice or a recommendation to buy or sell any asset. Markets move quickly; figures are correct as sourced at the time of writing. Always do your own research before making financial decisions.
